Skip to content
Clinical Trial Events
BIO-Europe 2026

Talk Presenting Companies (Theatre A) track

Oncology: Blue Earth Therapeutics

Mon, Nov 9, 2026 · 1:00–1:15 PM CET Koelnmesse

About this session

Blue Earth Therapeutics is a clinical-stage radiopharmaceutical company advancing the next generation of targeted radiopharmaceutical therapies with the aim of transforming the treatment of cancer. Our mission is to develop radiopharmaceutical therapies that result in improved patient outcomes by delivering high radiation doses to tumours, without compromising on normal organ safety. Founded in 2021 as a subsidiary of Bracco Imaging, the company was then partly spun out with Series A financing in 2024.

Speaker